Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immune profiling and minimal residue disease following stem cell transplantation in multiple myeloma

Immune profiling and minimal residue disease following stem cell transplantation in multiple myeloma

US Patent 10656144 · Granted May 19, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antimicrobial detergent composition comprising a polyester-polyether polymer and2025
Single-domain antibodies against CD33 and constructs thereof2025
Single-domain antibodies against CLL1 and constructs thereof2024
Binding agonist for treatment of neurological and other disorders2021
Methods of determining IMiDS resistance in plasma cell disorders2020
Methods of determining IMiDS resistance in plasma cell disorders2020
Methods of determining IMiDS resistance in plasma cell disorders2020
Phase change memory and fabrication method thereof2019
Semiconductor structures and fabrication methods thereof2019
Anti-tumor use of anagrelide and derivatives thereof2018
Binding agonist for treatment of neurological and other disorders2018
2,3-dihydroimidazol[1,2-C]pyrimidin-5(1-H)-one based ipoprotein-associated phosp2017